State of New Jersey Common Pension Fund D
NBIX icon

State of New Jersey Common Pension Fund D’s Neurocrine Biosciences NBIX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.2M Sell
30,829
-3,246
-10% -$482K 0.02% 571
2026
Q1 		$4.49M Buy
34,075
+145
+0.4% +$19.2K 0.02% 597
2025
Q4 		$4.81M Sell
33,930
-935
-3% -$135K 0.02% 591
2025
Q3 		$4.89M Buy
34,865
+891
+3% +$121K 0.02% 583
2025
Q2 		$4.27M Sell
33,974
-260
-0.8% -$29.8K 0.02% 596
2025
Q1 		$3.79M Sell
34,234
-3,962
-10% -$502K 0.02% 629
2024
Q4 		$5.21M Hold
38,196
– – 0.02% 574
2024
Q3 		$4.4M Hold
38,196
– – 0.02% 617
2024
Q2 		$5.26M Sell
38,196
-18,287
-32% -$2.51M 0.02% 531
2024
Q1 		$7.79M Hold
56,483
– – 0.02% 551
2023
Q4 		$7.44M Hold
56,483
– – 0.03% 536
2023
Q3 		$6.35M Hold
56,483
– – 0.02% 560
2023
Q2 		$5.33M Hold
56,483
– – 0.02% 632
2023
Q1 		$5.72M Hold
56,483
– – 0.02% 608
2022
Q4 		$6.75M Hold
56,483
– – 0.03% 540
2022
Q3 		$6M Sell
56,483
-1,274
-2% -$129K 0.02% 562
2022
Q2 		$5.63M Hold
57,757
– – 0.02% 602
2022
Q1 		$5.42M Sell
57,757
-2,557
-4% -$217K 0.02% 675
2021
Q4 		$5.14M Buy
60,314
+1,414
+2% +$130K 0.01% 736
2021
Q3 		$5.65M Buy
58,900
+1,364
+2% +$129K 0.02% 684
2021
Q2 		$5.6M Buy
57,536
+1,215
+2% +$116K 0.02% 700
2021
Q1 		$5.48M Sell
56,321
-3,294
-6% -$345K 0.02% 705
2020
Q4 		$5.71M Sell
59,615
-2,204
-4% -$213K 0.02% 654
2020
Q3 		$5.95M Sell
61,819
-813
-1% -$94K 0.02% 593
2020
Q2 		$7.64M Sell
62,632
-3,107
-5% -$343K 0.03% 487
2020
Q1 		$5.69M Hold
65,739
– – 0.03% 538
2019
Q4 		$7.07M Sell
65,739
-6,561
-9% -$687K 0.03% 586
2019
Q3 		$6.51M Buy
+72,300
New +$6.75M 0.03% 631

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State of New Jersey Common Pension Fund D's NBIX Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Neurocrine Biosciences (NBIX) stake by 9.5% in Q2 2026, selling an estimated $482K and leaving 30,829 shares worth $5.2M. The position accounts for 0.02% of the portfolio, ranked #571.

State of New Jersey Common Pension Fund D first reported a position in NBIX in Q3 2019 and has held it in 28 quarters since. The position peaked at $7.79M in Q1 2024. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • State of New Jersey Common Pension Fund D held 30,829 shares of Neurocrine Biosciences worth $5.2M as of Q2 2026.
  • State of New Jersey Common Pension Fund D sold 3,246 Neurocrine Biosciences shares in Q2 2026, an estimated $482K.
  • Neurocrine Biosciences made up 0.02% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #571 holding.
  • State of New Jersey Common Pension Fund D first reported a position in Neurocrine Biosciences in Q3 2019 and has held it in 28 quarters since.
  • State of New Jersey Common Pension Fund D's Neurocrine Biosciences position peaked at $7.79M in Q1 2024.
  • 781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.